2020
DOI: 10.24110/0031-403x-2020-99-2-8-15
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal Screening for Primary Immunodeficiency and Т-/B- Cell Lymphopenia as the Basis for the Formation of Risk Groups for Children With Congenital Pathologies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 0 publications
0
1
0
2
Order By: Relevance
“…Диагностика ПИДС, как правило, проходит в несколько этапов [14,15] V этап -генетическое исследование (определение дефекта).…”
Section: клиническая практика / Clinical Practiceunclassified
See 1 more Smart Citation
“…Диагностика ПИДС, как правило, проходит в несколько этапов [14,15] V этап -генетическое исследование (определение дефекта).…”
Section: клиническая практика / Clinical Practiceunclassified
“…Кольца TREC сопровождают созревание практически всех T-лимфоцитов, KREC -всех В-лимфоцитов и, таким образом, могут служить маркерами их количества [14]. Снижение количества TREC и KREC в крови свидетельствует о наличии иммунодефицитных состояний, выявление которых позволяет разработать эффективную программу мониторинга и постнатального сопровождения детей [15,16].…”
Section: клиническая практика / Clinical Practiceunclassified
“…A method for multiplex real-time PCR that makes it possible to detect defects in T and B cells generation by simultaneously measuring TREC and KREC copy numbers has been developed [ 14 , 15 ]. Mass screening for the TREC/KREC level could help us classify an infant as a risk group patient based on their immunological profile as early as in the neonatal period; this will increase the survival rate of infants with an immune-related pathology and reduce expenses [ 16 , 17 , 18 ]. This approach has other advantages, including high sensitivity, high throughput capacity, relatively low cost, and the possibility of using DNA isolated from the minimum volume of a blood sample collected using Guthrie cards [ 6 , 16 , 19 ].…”
Section: Introductionmentioning
confidence: 99%